Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ARCT Arcturus Therapeutics

14.820
+0.840+6.01%
Close 09/30 16:00 ET
14.790
-0.030-0.20%
Post Mkt Price 09/30 16:22 ET
High
15.581
Open
14.020
Turnover
5.38M
Low
13.970
Pre Close
13.980
Volume
358.59K
Market Cap
393.86M
P/E(TTM)
Loss
52wk High
48.750
Shares
26.58M
P/E(Static)
Loss
52wk Low
11.700
Float Cap
335.41M
Bid/Ask %
-33.33%
Historical High
129.710
Shs Float
22.63M
Volume Ratio
0.73
Historical Low
4.110
Dividend TTM
--
Div Yield TTM
--
P/B
2.31
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.58%
Amplitude
11.53%
Avg Price
14.996
Lot Size
1
Float Cap
335.41M
Bid/Ask %
-33.33%
Historical High
129.710
Shs Float
22.63M
Volume Ratio
0.73
Historical Low
4.110
Dividend TTM
--
P/B
2.31
Dividend LFY
--
Turnover Ratio
1.58%
Amplitude
11.53%
Avg Price
14.996
Lot Size
1
Price Forecast

No Data

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
Arcturus Therapeutics Holdings, Inc. develops pharmaceuticals. It is a clinical-stage mRNA medicines and vaccines company, which focuses on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. The firm's products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
CEO: Mr. Joseph E. Payne
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...